BD is one of the world's largest medical technology companies producing and marketing medical devices, medical systems and reagents, and is committed to improving human health around the world.BD focuses on improving drug treatments, increasing the quality and speed of diagnosis of infectious diseases, and advancing the research and discovery of novel medicines and vaccines.BD has a strong research and development capability to fight the world's most difficult diseases. BD has strong R&D capabilities to fight many of the world's toughest diseases. Founded in 1897 in New York City and headquartered in Franklin Lakes, New Jersey, the company employs more than 25,000 people in approximately 50 countries. The company serves healthcare organizations, life science research institutes, clinical laboratories, industrial units and the general public. For more information, please visit: www.bd.com
Long and illustrious 100-year history
BD began manufacturing glass and metal syringes and thermometers in 1898.
1924 BD started to produce syringes for insulin.
In the 1940s BD creatively invented the venous blood specialty collection system and a range of other specimen collection products.
1961 BD invents and produces the world's first disposable plastic syringe and disposable medical needle, leading the world into the phase of disposable medical products.
1966 BD is recognized by Fortune magazine as one of the top 500 companies in the U.S. for the first time, and has been ranked among the Fortune 500 many times since.
1973 BD introduces the world's first commercial flow cytometer.
1975 BD produces the world's first BACTEC110 blood culture instrument.
1986 BD introduces the first two-color fluorescent direct labeling reagent in the history of cell analysis.
1992-1996 BD is the first to introduce self-destructing vaccine syringes and a new generation of safe-injection disposable needles, strongly supporting the safe-injection programs of UNICEF and the World Health Organization.
1995 BD produces the only fully automated four-color flow cytometric sorter in the world today.
By the 1990s BD had established and maintained dominance in a number of products and was a strong competitor in the international marketplace.
Solid corporate strength
BD has now become a multinational company operating more than 10,000 products, the world's largest supplier of syringes and medical disposable products, and BD syringe products account for 45% of the world's total market share, accounting for 80% of the total amount of the United States and Europe.
All of the company's products on the market follow the highest standards in the industry and have passed ISO international quality certification.
In 2005, the company's global sales reached 5.4 billion U.S. dollars, with nearly 300 million U.S. dollars spent on research and development.
BD has acquired more than a dozen related medical device and medical equipment companies in the course of more than 100 years of development with its strong competitive advantage, making the company's scale of operation, market share and overall competitiveness a leap forward, which has attracted the attention of peers around the world.
Global Footprint
BD currently has branch offices, research and development centers, and manufacturing plants in more than 50 countries and regions, with operations on six continents and more than 25,000 employees worldwide.
The Company's Businesses
BD's businesses*** are organized into three main categories: BD Medical Systems, BD Bioscience Systems, and BD Diagnostic Systems
BD Medical Systems---Medical Systems consists of four divisions: Hospital Systems, Diabetic Care Systems, Ophthalmology Systems, and Pharmaceutical Systems. The products of the hospital system mainly include medical syringes, intravenous cannula needles, anesthesia products and scalpels. The Diabetes Care System offers insulin syringes, pen needles, and diabetes care products. Ophthalmic Systems mainly provides ophthalmic scalpels and ancillary products and LASIK laminators. Pharmaceutical Systems manufactures prefilled syringes for use by pharmaceutical companies.
BD Bioscience Systems - Products include flow cytometers, monoclonal antibody series products, reagents for bioscience research, cell culture and laboratory supplies and molecular biology products for genetic research.
BD Diagnostics---Diagnostic system is divided into specimen analysis pre-treatment system and diagnostic system. Specimen pre-analytical processing systems include vacuum blood collection systems, hematocrit specimen collection and testing systems, urine specimen collection systems, peripheral blood routine and safety sampling systems, arterial blood gas specimen collection systems, specimen collection waste collection systems , blood bag products and so on. Diagnostic Systems provides the market with finished and dry powder media, manual duplex culture bottles, fully automated blood culture systems, fully automated and semi-automated bacterial identification and drug sensitization systems, fully automated and manual mycobacterial culture and drug sensitization systems, fluorescent probe testing systems and medical error control systems centered on specimen management.
Development of BD in China
As early as the beginning of the twentieth century, BD's thermometers, reusable syringes, and other products entered China through the International Red Cross Organization and other organizations to serve the public.
BD formally sent staff to register and establish a representative office in China in 1994 to carry out business in China. In August of the following year, BD invested 25 million U.S. dollars in the Suzhou Industrial Park in China to establish a production enterprise --- Suzhou BD Medical Devices Co. BD's rapid development in China, currently established --- BD Medical Devices (Shanghai) Co.
BD in the world's advanced medical technology into China at the same time pay more attention to the exchange with health care workers and patients, is committed to improving the medical environment of the whole society, to improve the public's standard of medical care.
BD, as a partner of various international organizations (WHO, UNICEF), has been actively involved in supporting China's immunization and safe injection activities, and has conducted a series of safe injection lectures for healthcare workers across the country.
BD has also worked closely with the Nursing Association and the Anesthesia Association to hold a series of workshops, and has invited renowned professors and scholars from home and abroad to introduce international advanced medical technologies, such as combined anesthesia and painless labor and delivery, new concepts of intravenous fluids, comprehensive solutions for clinical laboratories and infection control, and flow cytometry symposiums, which have won unanimous acclaim in the healthcare community.
BD has also funded and collaborated with the HOPE Foundation to conduct a five-year diabetes education program in China.
Outlook
BD, a leader in quality and innovation for over 100 years, will continue to expand its presence in Asia and China, and will work with all levels of government and healthcare organizations to bring the latest medical technology to China to serve the public.
SUZHOU BD MEDICAL DEVICES CO.,LTD
Suzhou BD Medical Devices Co.,LTD, the manufacturing plant of BD in China, is located in Suzhou Industrial Park, on the beautiful shore of Jinji Lake, and the foundation stone was laid in August 1995, and the plant was officially inaugurated on October 26th 1996, which is located in Suzhou Industrial Park. China's Vice Premier Li Lanqing and Singapore's Vice Premier Lee Hsien Loong attended the grand inauguration ceremony.
Suzhou Bidi has a total investment of 25 million US dollars, covers an area of 20,000 square meters, plant area of 10,000 square meters. It has a clean room of 100,000 grade with an area of 2,200 square meters, and was awarded ISO9002 and ISO13488 international quality certificates in June 1998, and was awarded the CE marking in December 1998, which provides a passport for Suzhou BD's products to enter the European market.
Production
Suzhou BD mainly produces products for BD Medical Systems, including disposable intravenous indwelling needles of the second generation (Insyte) and the fourth generation (Intima-II), disposable vacuum blood collection needle components (BCS), disposable heparin caps (PRN), disposable anesthesia puncture kits (AS TRAY); and a new generation of Single-use self-destructing syringe SoloShotTM IX.
The Intima-II is one of BD's series of venous indwelling needles, which is specially designed by BD based on the Chinese nurses' single-winged approach to holding the needle. It integrates the cannula, extension tubing and heparin cap together. The design of the side hole of the needle and the soft catheter provide patients with safe and comfortable intravenous infusion. The combined anesthesia kits manufactured by Suzhou Bidi are mainly used for regional block anesthesia and pain management. The new generation of SoloShotTM IX self-destructing syringes is used to meet the demand for self-destructing syringes for immunization in China, in support of the Safe Injection Program of the Ministry of Health, UNICEF and the World Health Organization. BD's self-destructing syringes have been used for more than one billion vaccine injections in different countries around the world.
Disposable intravenous indwelling needles, single-use anesthesia puncture kits, single-use vacuum blood collection needle components (BCS), single-use heparin caps (PRN), and SoloShotTM IX self-destructing syringes are assembled from imported components. The key components of the main product Intima-II Intravenous Indwelling Needle (IVIN), such as syringes, catheters and isolation plugs are also imported components.SoloShotTM IX self-destructing syringes are in compliance with the standards of the World Health Organization (WHO), and have passed its testing and certification. The main raw materials for the combined anesthesia kit are sourced from Bidi in the US. In addition, Suzhou BD will be the global supply base for BD heparin cap products, and the epidural anesthesia kits produced in the factory are also exported to Japan and other countries.
Quality assurance and quality excellence
First-class products come from first-class production equipment, production technology, production management and first-class staff.
Suzhou Bidi has several production and packaging lines for indwelling needles, anesthesia kits, and vaccine injectors from Europe and the United States respectively, as well as an injection molding workshop. The raw materials for the production come from world-class global BD affiliates and suppliers designated and recognized by BD headquarters in the United States, Germany, Spain and Singapore.
The whole production process is in strict accordance with the requirements of ISO system for incoming inspection, process inspection and finished product inspection.
Suzhou BD has a first-class microbiology and physical and chemical laboratory, the series of the United States, France, New Zealand, Spain, the introduction of a full set of new imported testing and experimental equipment, such as autoclave, constant temperature incubator, pure water system and ultra-clean workbench and so on. Laboratory technicians have undergone strict professional and technical training, and the inspection and operation procedures follow the requirements of ISO, BD Group and national regulations to ensure that the products reach world-class quality.
Suzhou BD also has the first-class facilities of fully automatic ethylene oxide sterilization system, the main testing equipment and reagents are from the United States, ethylene oxide sterilization in accordance with the requirements of ISO11135 and EN550 for strict sterilization quality control. In September 2000, we obtained the sanitary license for disinfection issued by Jiangsu Provincial Department of Health, which allows us to undertake external disinfection business. At present, we have been cooperating with a multinational company for many years, and both sides have achieved good benefits.
Continuous vocational education and training of employees is a long-term strategy of Suzhou BD. All production line operators, technicians, and managers of Suzhou BD have gone through strict pre-employment and on-the-job training. Some of the best employees are also sent to BD University for professional management knowledge and skills training. The continuous improvement of personnel's professional quality and ability provides a guarantee for the production of first-class quality products and the provision of first-class quality services.
Suzhou BD also established a set of perfect customer service system, focusing on communication with medical staff and patients, and provide timely and good after-sales service to meet the requirements of customers at different levels. At present, we have established long-term business relationships with many hospitals in Suzhou, Shanghai and Beijing. With the strong R&D capability of BD Asia Pacific R&D Center, Suzhou BD continuously improves its products and introduces the world's advanced medical products into China according to the feedback from customers and the demand and development of the Chinese market.
At present, BD's products are not only widely used in large and medium-sized cities in China, but also have been exported to all over the world.
Committed to first-class technology, first-class service. Focus on customers, continuous improvement, and help all human beings to live a healthy life. This is the consistent quality policy of BD Group.
Development Outlook
In 2002, BD Asia-Pacific headquarter established the BD Asia-Pacific Clinical Laboratory Systems Training Center in Suzhou, BD. The training center has first-class teaching facilities, a full set of imported laboratory instruments, and experienced product experts for training. It has delivered a large number of technical professionals to customers in the Asia-Pacific region.
The promotion of 6-Sigma and Lean Manufacturing within the group has made Suzhou BD's production process and technology more mature, and enabled the company to utilize its corporate resources more effectively to continuously improve and refine product quality and increase customer satisfaction with BD's products.
Helping human beings to live a healthy life is the eternal purpose of BD!